Following on from our March 2019 report, this latest issue of Healthcare & Life Sciences Review France takes a closer look at the wider French life sciences value chain and the spirit of innovation and reform sweeping the nation. A reform-minded and business-oriented administration under President Emmanuel Macron has already made significant progress, with…
See Full ReportCountry Reports
France – under the business-minded administration of President Emmanuel Macron – has been rapidly climbing investor priority rankings in recent years. This report examines the potential impact of a swathe of ambitious recently-approved reforms and a new mood of optimism sweeping the country. These stand to impact the entire strategic direction of the French…
See Full Report
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and…
See Full Report
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and…
See Full Report
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the country’s healthcare and pharma sectors. It offers companies, investors, policymakers, and…
See Full Report